ibuprofen has been researched along with Infections, Coronavirus in 13 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| " Oral-dosed ATV041 resulted in favorable bioavailability and rapid tissue distribution of GS-441524 and ibuprofen." | 1.91 | Nonsteroidal anti-inflammatory drugs (NSAIDs) and nucleotide analog GS-441524 conjugates with potent in vivo efficacy against coronaviruses. ( Chen, Q; Cong, F; Li, Y; Luo, Y; Qiu, J; Zhang, X; Zhou, Q; Zhu, Y, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 13 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Q | 1 |
| Luo, Y | 1 |
| Zhu, Y | 1 |
| Chen, Q | 1 |
| Qiu, J | 1 |
| Cong, F | 1 |
| Li, Y | 1 |
| Zhang, X | 1 |
| Sodhi, M | 1 |
| Etminan, M | 1 |
| MaassenVanDenBrink, A | 1 |
| de Vries, T | 1 |
| Danser, AHJ | 1 |
| Vanegas Ramirez, A | 1 |
| Efe, D | 1 |
| Fischer, M | 1 |
| Zolk, O | 1 |
| Hafner, S | 1 |
| Schmidt, CQ | 1 |
| Veljkovic, V | 4 |
| Vergara-Alert, J | 4 |
| Segalés, J | 4 |
| Paessler, S | 4 |
| Martins-Filho, PR | 1 |
| do Nascimento-Júnior, EM | 1 |
| Santos, VS | 1 |
| Moore, N | 1 |
| Carleton, B | 1 |
| Blin, P | 1 |
| Bosco-Levy, P | 1 |
| Droz, C | 1 |
| Smart, L | 1 |
| Fawkes, N | 1 |
| Goggin, P | 1 |
| Pennick, G | 1 |
| Rainsford, KD | 1 |
| Charlesworth, B | 1 |
| Shah, N | 1 |
| Vosu, J | 1 |
| Britton, P | 1 |
| Howard-Jones, A | 1 |
| Isaacs, D | 1 |
| Kesson, A | 1 |
| Khatami, A | 1 |
| Marais, B | 1 |
| Nayda, C | 1 |
| Outhred, A | 1 |
| Kelleni, MT | 1 |
| Sütő, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Extended Compassionate Use Program (UCA) With Inhalational Ibuprofen in Patients With Acute Respiratory Pathology, Mediated by COVID-19.[NCT04382768] | 40 participants (Anticipated) | Interventional | 2020-05-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ibuprofen and Infections, Coronavirus
| Article | Year |
|---|---|
COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammato | 2020 |
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality.
Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents, Non-Steroidal; Coronavirus Infections; CO | 2020 |
11 other studies available for ibuprofen and Infections, Coronavirus
| Article | Year |
|---|---|
Nonsteroidal anti-inflammatory drugs (NSAIDs) and nucleotide analog GS-441524 conjugates with potent in vivo efficacy against coronaviruses.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Coronavirus; | 2023 |
EMA advice on the use of NSAIDs for Covid-19.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 | 2020 |
Safety of Ibuprofen in Patients With COVID-19: Causal or Confounded?
Topics: Acetaminophen; Antipyretics; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ibuprofen; P | 2020 |
Headache medication and the COVID-19 pandemic.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inh | 2020 |
Drug-induced vasculitis in a patient with COVID-19.
Topics: Anti-Bacterial Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Ibuprofen; | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target.
Topics: Actins; Angiotensin-Converting Enzyme 2; Betacoronavirus; China; Computer Simulation; Coronavirus In | 2020 |
No current evidence supporting risk of using Ibuprofen in patients with COVID-19.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes | 2020 |
Does Ibuprofen Worsen COVID-19?
Topics: Acute Disease; Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents, Non-Steroidal; Betacoronav | 2020 |
Is the risk of ibuprofen or other non-steroidal anti-inflammatory drugs increased in COVID-19?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Coronavirus Infections; COVID-19; COVID-19 Drug Trea | 2020 |
ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents | 2020 |
The role of ibuprofen in the treatment of coronavirus infection
Topics: Coronavirus Infections; Humans; Ibuprofen; Pneumonia, Viral | 2020 |